MedPath

Megestrol Acetate

Megestrol Acetate Oral Suspension

Approved
Approval ID

95dfc24a-5744-4ddf-8809-86184142a372

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 18, 2023

Manufacturers
FDA

McKesson Corporation dba SKY Packaging

DUNS: 140529962

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63739-549
Application NumberANDA075671
Product Classification
M
Marketing Category
C73584
G
Generic Name
Megestrol Acetate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 18, 2023
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 400 mg in 10 mL
Code: TJ2M0FR8ES
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Megestrol Acetate - FDA Drug Approval Details